News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Ocrelizumab shown to be effective in both progressive, relapsing MS

January 12, 2017

Clinical trials show ocrelizumab can reduce new attacks in patients with relapsing MS, slow symptom progression in primary progressive MS
Learn more

21st Century Cures Act Passes U.S. Senate

December 08, 2016

New legislation contains an important provision for those affected by multiple sclerosis and other neurological diseases.
Learn more

Study suggests MS drug may reverse some physical disability

October 20, 2016

A drug used to treat multiple sclerosis, alemtuzumab, was found to reverse some of the physical disability caused by the disease.
Learn more

New research strengthens genetics, MS link

October 19, 2016

n a large-scale, genome-wide analysis of more than 110,000 samples, researchers identified 200 genetic loci associated with multiple sclerosis.
Learn more

Improper criteria use can lead to MS misdiagnosis

September 12, 2016

Clinicians and researchers have known for decades that multiple sclerosis misdiagnosis is a problem. Authors of a new study define possible reasons why they are misdiagnosed.
Learn more

CVS Caremark to remove three MS drugs from 2017 formulary

August 29, 2016

CVS Caremark recently announced that it will remove three MS drugs, Avonex, Plegridy, and Extavia from its formulary at the start of the new year.
Learn more

Study suggests antibody may have therapeutic effect on MS

July 21, 2016

Researchers have developed an antibody with potential therapeutic effects against multiple sclerosis that opens up a new strategy for controlling the disease.
Learn more

Researchers find gut bacteria, MS link

July 13, 2016

In a new study, researchers detected clear evidence of changes that tie together bacteria living in the gut and immunological disorders such as multiple sclerosis
Learn more

Study finds hippocampus inflammation, depression link

July 08, 2016

A new study suggests that inflammation of the hippocampus – a region of the brain implicated in the genesis and maintenance of depression and in the pathology of multiple sclerosis – could be the contributing cause of high rates of depression in MS.
Learn more

Ocrelizumab shown to be effective in both progressive, relapsing MS

January 12, 2017

Clinical trials show ocrelizumab can reduce new attacks in patients with relapsing MS, slow symptom progression in primary progressive MS
Learn more

21st Century Cures Act Passes U.S. Senate

December 08, 2016

New legislation contains an important provision for those affected by multiple sclerosis and other neurological diseases.
Learn more

Study suggests MS drug may reverse some physical disability

October 20, 2016

A drug used to treat multiple sclerosis, alemtuzumab, was found to reverse some of the physical disability caused by the disease.
Learn more

New research strengthens genetics, MS link

October 19, 2016

n a large-scale, genome-wide analysis of more than 110,000 samples, researchers identified 200 genetic loci associated with multiple sclerosis.
Learn more

Improper criteria use can lead to MS misdiagnosis

September 12, 2016

Clinicians and researchers have known for decades that multiple sclerosis misdiagnosis is a problem. Authors of a new study define possible reasons why they are misdiagnosed.
Learn more

CVS Caremark to remove three MS drugs from 2017 formulary

August 29, 2016

CVS Caremark recently announced that it will remove three MS drugs, Avonex, Plegridy, and Extavia from its formulary at the start of the new year.
Learn more

Study suggests antibody may have therapeutic effect on MS

July 21, 2016

Researchers have developed an antibody with potential therapeutic effects against multiple sclerosis that opens up a new strategy for controlling the disease.
Learn more

Researchers find gut bacteria, MS link

July 13, 2016

In a new study, researchers detected clear evidence of changes that tie together bacteria living in the gut and immunological disorders such as multiple sclerosis
Learn more

Study finds hippocampus inflammation, depression link

July 08, 2016

A new study suggests that inflammation of the hippocampus – a region of the brain implicated in the genesis and maintenance of depression and in the pathology of multiple sclerosis – could be the contributing cause of high rates of depression in MS.
Learn more

New study suggests MS risk, obesity link

July 01, 2016

A new study suggests that elevated body mass index could be an important, and potentially modifiable, risk factor for multiple sclerosis.
Learn more

FDA grants Priority Review for ocrelizumab

June 29, 2016

Ocrevus would be the first and only treatment indicated for both forms of MS, which affect approximately 95 percent of people at diagnosis.
Learn more

Researchers image neuroinflammation in MS mouse model

June 24, 2016

Molecular imaging is bringing researchers closer to identifying autoimmune inflammation triggers in multiple sclerosis while providing a means of evaluating next-generation therapies for MS
Learn more

New study links four genes to MS

June 22, 2016

Researchers have identified four new risk genes that are altered in German patients with multiple sclerosis.
Learn more

Study suggests microbleeds, MS disability link

June 20, 2016

A new study suggests that leaky blood vessels in the brain, called cerebral microbleeds, are linked to increased physical and cognitive disability in patients with multiple sclerosis.
Learn more

Researchers find sleep apnea, cognitive dysfunction link

June 15, 2016

A new study found a link between sleep apnea severity and cognitive dysfunction in patients with MS.
Learn more

New stem cell treatment shows promise in MS

June 14, 2016

A new study shows the use of chemotherapy followed by autologous haematopoietic stem cell transplantation (aHSCT) has fully halted clinical relapses and development of new brain lesions without the need for ongoing medication.
Learn more

Dress4MS with Sharon Osbourne


Dress up to show your support for those affected with MS
Learn more

MS Focus Lending Library


Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more


Show More News